To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
type: MedicalStudy
description: A Single-Dose Comparative Bioavailability Study of Two Formulations of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release Tablets Under Fed Conditions
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2005-06
end date: 2005-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00881634
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Sandoz
study subject: Allergies
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Allergies

AI Analytics
type: Organization